Bryce Point Capital LLC Takes Position in Sotera Health (NASDAQ:SHC)

Bryce Point Capital LLC bought a new stake in Sotera Health (NASDAQ:SHC - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 130,424 shares of the company's stock, valued at approximately $1,784,000. Sotera Health makes up 0.5% of Bryce Point Capital LLC's investment portfolio, making the stock its 26th biggest position.

Several other large investors have also modified their holdings of SHC. Blue Trust Inc. lifted its holdings in Sotera Health by 164.3% during the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock worth $25,000 after buying an additional 1,140 shares during the last quarter. GAMMA Investing LLC lifted its stake in Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock worth $56,000 after purchasing an additional 1,121 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in Sotera Health by 39.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock worth $127,000 after purchasing an additional 2,627 shares during the period. iSAM Funds UK Ltd bought a new stake in Sotera Health during the third quarter valued at $259,000. Finally, Envestnet Portfolio Solutions Inc. raised its holdings in shares of Sotera Health by 17.3% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company's stock worth $217,000 after purchasing an additional 2,340 shares during the period. Institutional investors own 91.03% of the company's stock.

Wall Street Analyst Weigh In

Separately, Barclays lowered their price objective on shares of Sotera Health from $17.00 to $16.00 and set an "overweight" rating for the company in a research report on Friday, February 28th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $16.00.

Sotera Health Stock Performance

SHC stock traded down $0.33 during mid-day trading on Monday, reaching $10.01. The company had a trading volume of 633,169 shares, compared to its average volume of 1,178,299. Sotera Health has a one year low of $9.79 and a one year high of $17.08. The stock has a market capitalization of $2.84 billion, a P/E ratio of 40.13 and a beta of 1.88. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The stock's 50-day simple moving average is $12.61 and its two-hundred day simple moving average is $13.78.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.